Antitumor activity of <scp>the MEK</scp> inhibitor trametinib on intestinal polyp formation in <i>Apc</i><sup>Δ716</sup> mice involves stromal <scp>COX</scp>‐2
Teruaki Fujishita(Aichi Cancer Center), Masahiro Aoki(Aichi Cancer Center)
Cited by 9
Related Papers
Mechanism of Oncogenic Signal Activation by the Novel Fusion Kinase FGFR3–BAIAP2L1
|Molecular Cancer Therapeutics|2015|60